[go: up one dir, main page]

PL2021002T3 - Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu - Google Patents

Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu

Info

Publication number
PL2021002T3
PL2021002T3 PL07724794T PL07724794T PL2021002T3 PL 2021002 T3 PL2021002 T3 PL 2021002T3 PL 07724794 T PL07724794 T PL 07724794T PL 07724794 T PL07724794 T PL 07724794T PL 2021002 T3 PL2021002 T3 PL 2021002T3
Authority
PL
Poland
Prior art keywords
olmesartan medoxomil
pharmaceutical composition
medoxomil
olmesartan
subjecting
Prior art date
Application number
PL07724794T
Other languages
English (en)
Inventor
Matej Avanzo
Peterka Tanja Rozman
Igor Legen
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of PL2021002T3 publication Critical patent/PL2021002T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL07724794T 2006-05-04 2007-05-02 Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu PL2021002T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06009223A EP1891952B1 (en) 2006-05-04 2006-05-04 Pharmaceutical composition of olmesartan medoxomil
EP07724794A EP2021002B1 (en) 2006-05-04 2007-05-02 Pharmaceutical composition comprising olmesartan medoxomil
PCT/EP2007/003868 WO2007128478A2 (en) 2006-05-04 2007-05-02 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL2021002T3 true PL2021002T3 (pl) 2012-11-30

Family

ID=37076372

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07724794T PL2021002T3 (pl) 2006-05-04 2007-05-02 Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu

Country Status (8)

Country Link
US (1) US9707178B2 (pl)
EP (2) EP1891952B1 (pl)
AT (1) ATE526963T1 (pl)
CA (1) CA2651138C (pl)
ES (1) ES2388880T3 (pl)
PL (1) PL2021002T3 (pl)
SI (2) SI1891952T1 (pl)
WO (1) WO2007128478A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100237530A1 (en) 2006-06-27 2010-09-23 Daiichi Sankyo Company, Limited Compressed preparation
EP2228066A1 (en) * 2009-03-03 2010-09-15 LEK Pharmaceuticals d.d. Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
CA2785920A1 (en) 2010-01-05 2011-07-14 Ratiopharm Gmbh Solid oral dosage form containing olmesartan medoxomil
TR201005867A1 (tr) 2010-07-16 2012-02-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Olmesartan farmasötik bileşimleri.
JP5705562B2 (ja) * 2011-01-25 2015-04-22 沢井製薬株式会社 カンデサルタンシレキセチル含有錠剤及びその製造方法
WO2014002011A1 (en) * 2012-06-26 2014-01-03 Micro Labs Limited Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof
JPWO2014188729A1 (ja) * 2013-05-24 2017-02-23 持田製薬株式会社 経口用組成物
JP6653116B2 (ja) * 2014-08-27 2020-02-26 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
CA2061607C (en) 1991-02-21 1999-01-19 Hiroaki Yanagisawa 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2001234088B2 (en) * 2000-02-18 2005-12-01 Takeda Pharmaceutical Company Limited Tnf-alpha inhibitors
SK5992003A3 (en) * 2000-11-21 2003-11-04 Sankyo Co Medicinal composition comprising an angiotensin II receptor antagonist and one or more diuretics and use thereof
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
GB0325291D0 (en) * 2003-10-29 2003-12-03 Pfizer Ltd Novel combination
AU2005256634B2 (en) * 2004-06-23 2010-12-09 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists
EP1784398A1 (en) * 2004-09-02 2007-05-16 Teva Pharmaceutical Industries Ltd Purification of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
RU2394027C2 (ru) * 2004-10-27 2010-07-10 Ф. Хоффманн-Ля Рош Аг Новые индольные или бензимидазольные производные
US20060281800A1 (en) * 2005-04-12 2006-12-14 Glenmark Pharmaceuticals Limited Polymorphic form of olmesartan and process for its preparation
WO2007017135A2 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil

Also Published As

Publication number Publication date
WO2007128478A3 (en) 2008-02-07
WO2007128478A2 (en) 2007-11-15
EP1891952A1 (en) 2008-02-27
SI2021002T1 (sl) 2012-10-30
EP2021002A2 (en) 2009-02-11
CA2651138C (en) 2016-02-16
EP1891952B1 (en) 2011-10-05
ES2388880T3 (es) 2012-10-19
US20090238871A1 (en) 2009-09-24
EP2021002B1 (en) 2012-05-30
SI1891952T1 (sl) 2012-02-29
US9707178B2 (en) 2017-07-18
CA2651138A1 (en) 2007-11-15
ATE526963T1 (de) 2011-10-15

Similar Documents

Publication Publication Date Title
SI2021002T1 (sl) Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
BR112012011328A2 (pt) inibidores de akt
MX2010004493A (es) Compuestos de tropano.
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MX2010002341A (es) Derivados de bencimidazol usados como agonistas del receptor x de farnesoide.
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2009074247A8 (de) Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
WO2011047055A3 (en) Novel mek inhibitors, useful in the treatment of diseases
MX2011008360A (es) Derivados de piridazinona sustituida con heteroarilo.
TW200611897A (en) Organic compounds
NO20085317L (no) Imidazoazepinonforbindelser
WO2007130821A3 (en) Mglur5 modulators ii
WO2010047592A3 (en) Preservation mixture and use thereof
WO2009062874A3 (en) Benzimidazole derivatives and their use as fxr agonists
MX2009008221A (es) Antagonista de receptor de cromeno s1p1.
WO2007095021A3 (en) Novel compounds
WO2008098143A3 (en) Antimicrobial compounds and methods of use
DE602007005387D1 (de) Ptors
WO2010059639A3 (en) Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
WO2007145563A8 (en) Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
MY180567A (en) Arylcyclopropylacetamide derivatives useful as glucokinase activators
IL209732A0 (en) Salicylamide derivatives as nicotinic alpha 7 modulators